LEAP-005: A phase II multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors-Results from the gastric cancer cohort.

Autores: Chung, H. C.; Lwin, Z.; Gómez-Roca, C.; Longo, F.; Yanez, E.; Castañón Álvarez, Eduardo; Graham, D.; Doherty, M.; Cassier, P.; López, J. S.; Basu, B.; Hendifar, A. E.; Maurice-Dror, C.; Gill, S. S.; Ghori, R.; Kubiak, P.; Jin, F.; Norwood, K. G.; Saada-Bouzid, E.